NCT04521686 2026-04-22Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT07138001 2025-08-22Phase 2 Clinical Trial of KH617Chengdu Kanghong Pharmaceutical Group Co., Ltd.Phase 2 Not yet recruiting60 enrolled